Kevin J. Harvey

Dr. Harvey is responsible for leading all Aviva Systems Biology and Genway Biotech operations with a focus on delivering profitable growth initiatives across the Company. He brings over 18 years of biotechnology experience and a proven track record of delivering profitable growth within the antibody product segments. Most recently Dr. Harvey has served as General Manager of Thermo Fisher Scientific’s antibody business where he had financial and product development responsibility for the business segment. He has held numerous leadership roles at Affymetrix (acquired by Thermo Fisher Scientific) and EMD Millipore Inc. (Merck KGaA), where he was responsible for research and development, product management, business development, and commercial strategy. Dr. Harvey has a Ph.D. in Microbiology and Immunology from the University of Illinois of Chicago and held a Postdoctoral Fellowship at the University of California, San Diego.